|
COPYRIGHT 2005 Thomson Financial Inc.
To head off future vaccine shortages like the one that hit this flu season, the Food and Drug Administration is improving communications channels with international drug regulators to ensure earlier warning about potential supply-line problems and seeking more companies to provide vaccine for the U.S. market. So said Jesse Goodman, MD, director of FDA's Center for Biologics, Evaluation and Research, at a Feb. 10 hearing of the House Government Reform Committee....
Read the full article for free courtesy of your local library.
|